Prognostic Value of Specific High-Risk Cytogenetic Abnormalities and Ethnicity in Outcomes after Autologous Stem Cell Transplant in Multiple Myeloma

被引：0
|
作者：
Basher, Fahmin [1 ,2 ]
Sanchez, Sandra [3 ]
Hoffman, James E. [4 ]
Lekakis, Lazaros J. [4 ]
Pereira, Denise [5 ]
机构：
[1] Duke Univ, Med Ctr, Dept Med, Miami, FL USA
[2] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Pathol & Lab Med, Div Hematopathol, Miami, FL USA
[4] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[5] Univ Miami, Sylvester Comprehens Canc Ctr, Div Transplantat & Cellular Therapy, Miami, FL USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-154303
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5041
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Prognostic Implications of Multiple Cytogenetic High-Risk Abnormalities in Patients with Newly Diagnosed Multiple Myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Hwa, Yi L.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kyle, Robert A.
    Kumar, Shaji
    BLOOD, 2016, 128 (22)
  • [2] PROGNOSTIC IMPLICATIONS OF MULTIPLE CYTOGENETIC HIGH-RISK ABNORMALITIES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Binder, M.
    Rajkumar, S. V.
    Ketterling, R. P.
    Dispenzieri, A.
    Lacy, M. Q.
    Gertz, M. A.
    Buadi, F. K.
    Hayman, S. R.
    Hwa, Y. L.
    Zeldenrust, S. R.
    Lust, J. A.
    Russell, S. J.
    Leung, N.
    Kapoor, P.
    Go, R. S.
    Gonsalves, W. I.
    Kyle, R. A.
    Kumar, S. K.
    HAEMATOLOGICA, 2017, 102 : 107 - 107
  • [3] Lenalidomide: Based maintenance after autologous hematopoietic stem cell transplant for patients with high-risk multiple myeloma.
    Pasvolsky, Oren
    Milton, Denai R.
    Rauf, Mikael
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer Ali
    Saini, Neeraj
    Ramdial, Jeremy L.
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Outcomes after Autologous Stem Cell Transplant in Patients with Relapsed Multiple Myeloma
    Lemieux, Christopher
    Craig, Juliana
    Iberri, David
    Arai, Sally
    Johnston, Laura J.
    Lowsky, Robert
    Muffly, Lori S.
    Shiraz, Parveen
    Liedtke, Michaela
    Rezvani, Andrew R.
    Frank, Matthew J.
    Weng, Wen-Kai
    Meyer, Everett H.
    Shizuru, Judith A.
    Negrin, Robert S.
    Miklos, David B.
    Sidana, Surbhi
    BLOOD, 2020, 136
  • [5] Early M protein immune reconstitution is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma after autologous hematopoietic stem cell transplantation
    Zhu, Huihui
    Li, Juan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S115 - S116
  • [6] Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
    Binder, M.
    Rajkumar, S. V.
    Ketterling, R. P.
    Greipp, P. T.
    Dispenzieri, A.
    Lacy, M. Q.
    Gertz, M. A.
    Buadi, F. K.
    Hayman, S. R.
    Hwa, Y. L.
    Zeldenrust, S. R.
    Lust, J. A.
    Russell, S. J.
    Leung, N.
    Kapoor, P.
    Go, R. S.
    Gonsalves, W. I.
    Kyle, R. A.
    Kumar, S. K.
    BLOOD CANCER JOURNAL, 2017, 7 : e600 - e600
  • [7] Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
    M Binder
    S V Rajkumar
    R P Ketterling
    P T Greipp
    A Dispenzieri
    M Q Lacy
    M A Gertz
    F K Buadi
    S R Hayman
    Y L Hwa
    S R Zeldenrust
    J A Lust
    S J Russell
    N Leung
    P Kapoor
    R S Go
    W I Gonsalves
    R A Kyle
    S K Kumar
    Blood Cancer Journal, 2017, 7 : e600 - e600
  • [8] Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Dingli, David
    Gonsalves, Wilson I.
    Kumar, Shaji
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Hogan, William J.
    MAYO CLINIC PROCEEDINGS, 2018, 93 (01) : 56 - 58
  • [9] Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Ahmed, Sairah
    Lin, Heather
    Baladandayuthapani, Veera
    Khan, Mubeen A.
    Lu, Gary
    Rondon, Gabriela
    Qureshi, Sofia
    Dinh, Yvonne T.
    Bashir, Qaiser
    Shah, Nina
    Parmar, Simrit
    Hosing, Chitra M.
    Popat, Uday
    Giralt, Sergio A.
    Orlowski, Robert Z.
    Shah, Jatin J.
    Champlin, Richard
    Qazilbash, Muzaffar H.
    BLOOD, 2011, 118 (21) : 156 - 157
  • [10] Outcome of Patients with Multiple Myeloma by Ethnicity in the Setting of Autologous Stem Cell Transplant
    Sasaki, Koji
    Bashir, Qaiser
    Shah, Nina
    Hosing, Chitra
    Popat, Uday R.
    Nieto, Yago
    Parmar, Simrit
    Shah, Jatin
    Weber, Donna
    Thomas, Sheeba
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S231 - S232
12345